Systems for Identifying New Drugs Are Often Faulty
Open accessAbstract
Screening potential anticancer agents to find ones promising enough to make human clinical trials worthwhile has not been as straightforward as researchers would like. Not only have very few of the drugs that showed anticancer activity in animals carrying transplanted human tumors--known as xenografts--made it into the clinic, but a recent study conducted at the National Cancer Institute suggests that the tests are also missing drugs that do work in humans, possibly because animals and humans do not handle the drugs exactly the same way. And attempts to use human cells in culture don9t seem to be faring any better, partly because cell culture provides no information about whether a drug will make it to the tumor site. To create better models of cancer development in humans, investigators are now drawing on knowledge of human cancer-related gene mutations to genetically alter mice so that they carry the same kinds of changes that lead to cancer in humans. The hope is that the mice will develop tumors that behave the same way the human tumors do.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Many potentially beneficial drugs have failed animal testing and been lost to patients, even though they would have been both safe and effective.
“Undoubtedly many potentially beneficial drugs have failed animal testing and been lost to patients, even though they would have been both safe and effective (36,37).”
From Limitations of Animal Studies for Predicting Toxicity in Clinical Trials (2019) · cites this paper as [37]
Cites
Still being checked.
Cited by
Sorted by citations
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials
Van Norman, G. A. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.10.008 · Cited by 709 · see citing works
“Undoubtedly many potentially beneficial drugs have failed animal testing and been lost to patients, even though they would have been both safe and effective (36,37).”
Apoptosis, p53, and tumor cell sensitivity to anticancer agents.
Brown, J. M., & Wouters, B. G. (1999) · PubMed · Cited by 696 · see citing works
Contributions of Human Tumor Xenografts to Anticancer Drug Development
Sausville, E. A., & Burger, A. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3627 · Cited by 348 · see citing works
3D Bioprinting of Tissue/Organ Models
Pati, F., Gantelius, J., & Svahn, H. A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201505062 · Cited by 303 · see citing works
Kim, B. S., Gao, G., Kim, J. Y., & Cho, D. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201801019 · Cited by 292 · see citing works
Systematic reviews of animal models: methodology versus epistemology
Greek, R., & Menache, A. (2013) · International Journal of Medical Sciences · doi:10.7150/ijms.5529 · Cited by 207 · see citing works
Gelmon, K. A., Eisenhauer, E. A., Harris, A. L., Ratain, M. J., & Workman, P. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1281 · Cited by 204 · see citing works
John, T., Kohler, D. M., Pintilie, M., Yanagawa, N., Pham, N., Li, M., Panchal, D., Hui, F., Meng, F., Shepherd, F. A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2224 · Cited by 176 · see citing works
New Insights into Toxicity and Drug Testing
Gowder, S. J. (2013) · InTech eBooks · doi:10.5772/55886 · Cited by 149 · see citing works
Discovering novel chemotherapeutic drugs for the third millennium
Garrett, M. D., & Workman, P. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00280-4 · Cited by 141 · see citing works
Mouse models in oncogenesis and cancer therapy
Céspedes, M. V., Casanova, I., Parreño, M., & Mangues, R. (2006) · Clinical & Translational Oncology · doi:10.1007/s12094-006-0177-7 · Cited by 130 · see citing works
Predicting the active doses in humans from animal studies: A novel approach in oncology
Rocchetti, M., Simeoni, M., Pesenti, E. A., Nicolao, G. D., & Poggesi, I. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.05.011 · Cited by 101 · see citing works
Genome sequencing in the clinic: the past, present, and future of genomic medicine
Prokop, J. W., May, T., Strong, K. A., Bilinovich, S. M., Bupp, C. P., Rajasekaran, S., Worthey, E. A., & Lazar, J. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00046.2018 · Cited by 87 · see citing works
The role of radiation-induced apoptosis as a determinant of tumor responses to radiation therapy
Rupnow, B. A., & Knox, S. J. (1999) · APOPTOSIS · doi:10.1023/a:1009675028784 · Cited by 86 · see citing works
The Importance of Mimicking Dermal-Epidermal Junction for Skin Tissue Engineering: A Review
Aleemardani, M., Trikić, M. Z., Green, N. H., & Claeyssens, F. (2021) · Bioengineering · doi:10.3390/bioengineering8110148 · Cited by 83 · see citing works
The Nuremberg Code subverts human health and safety by requiring animal modeling
Greek, R., Pippus, A., & Hansen, L. A. (2012) · BMC Medical Ethics · doi:10.1186/1472-6939-13-16 · Cited by 78 · see citing works
Persidis, A. (1998) · Nature Biotechnology · doi:10.1038/nbt0598-488 · Cited by 70 · see citing works
Utama, F. E., LeBaron, M. J., Neilson, L. M., Sultan, A., Parlow, A. F., Wagner, K.-U., & Rui, H. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06560 · Cited by 64 · see citing works
Animal models of soft-tissue sarcoma
Dodd, R. D., Mito, J., & Kirsch, D. G. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.005223 · Cited by 52 · see citing works
Folkvord, S., Ree, A. H., Furre, T., Halvorsen, T., & Flatmark, K. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.01.068 · Cited by 50 · see citing works
Stangelberger, A., Schally, A. V., Varga, J. L., Zarándi, M., Szepesházi, K., Armatis, P. E., & Halmos, G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.49.11.1 · Cited by 48 · see citing works
Vascularized 3D Human Skin Models in the Forefront of Dermatological Research
Rimal, R., Muduli, S., Desai, P., Marquez, A. B., Möller, M., Platzman, I., Spatz, J., & Singh, S. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303351 · Cited by 46 · see citing works
Animal models and conserved processes
Greek, R., & Rice, M. J. (2012) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-9-40 · Cited by 44 · see citing works
Tissue engineered tumor models
Ingram, M., Techy, G. B., Ward, B., Imam, S. A., Atkinson, R., Ho, H., & Cr, T. (2010) · Biotechnic & Histochemistry · doi:10.3109/10520295.2010.483655 · Cited by 35 · see citing works
Greek, R., & Hansen, L. A. (2013) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2013.06.002 · Cited by 33 · see citing works
The History and Implications of Testing Thalidomide on Animals
Greek, R., Shanks, N., & Rice, M. J. (2011) · The Journal of Philosophy Science & Law · doi:10.5840/jpsl20111133 · Cited by 33 · see citing works
Preclinical Screening for New Anticancer Agents
Burger, A. M., & Fiebig, H. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-9135-4_2 · Cited by 32 · see citing works
Animal Models in an Age of Personalized Medicine
Greek, R., Menache, A., & Rice, M. J. (2011) · Personalized Medicine · doi:10.2217/pme.11.89 · Cited by 30 · see citing works
Expression of Mouse Sialic Acid on Gangliosides of a Human Glioma Grown as a Xenograft in SCID Mice
Ecsedy, J., Holthaus, K. A., Yohe, H. C., & Seyfried, T. N. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730254.x · Cited by 29 · see citing works
A new mouse model for evaluating the immunotherapy of human colorectal cancer.
Hörig, H., Wainstein, A., Long, L., Kahn, D., Soni, S., Marcus, A., Edelmann, W., Kucherlapati, R., & Kaufman, H. L. (2001) · PubMed · Cited by 26 · see citing works
Animal Models in Drug Development
Greek, R. (2013) · InTech eBooks · doi:10.5772/53893 · Cited by 22 · see citing works
Immunological responses can have both pro- and antitumour effects: implications for immunotherapy
Stewart, T. J., Greeneltch, K. M., Lutsiak, M. E. C., & Abrams, S. I. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000233 · Cited by 21 · see citing works
Controlling Tissue Microenvironments: Biomimetics, Transport Phenomena, and Reacting Systems
Fisher, R. J., & Peattie, R. A. (2006) · Springer eBooks · doi:10.1007/10_018 · Cited by 19 · see citing works
From Reductionism to Holism: Systems-oriented Approaches in Cancer Research
Kienle, G. S., & Kiene, H. (2012) · Global Advances in Health and Medicine · doi:10.7453/gahmj.2012.1.5.015 · Cited by 18 · see citing works
Animal Models and the Development of an HIV Vaccine
Greek, R. (2012) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113.s8-001 · Cited by 17 · see citing works
Kim, H.-Y., Kim, J., Thi, H. T. H., Bang, O., Lee, W. S., & Hong, S. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1447-8 · Cited by 15 · see citing works
Human Stakeholders and the Use of Animals in Drug Development
Kramer, L. A., & Greek, R. (2018) · Business and Society Review · doi:10.1111/basr.12134 · Cited by 15 · see citing works
A Review of the Institute of Medicine’s Analysis of using Chimpanzees in Biomedical Research
Jones, R. C., & Greek, R. (2013) · Science and Engineering Ethics · doi:10.1007/s11948-013-9442-7 · Cited by 14 · see citing works
Human Tumor Xenograft Efficacy Models
Liu, M., & Hicklin, D. J. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-968-0_5 · Cited by 13 · see citing works
Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors
Wilkinson, R. W., Ross, E. L., Poulsom, R., Ilyas, M., Straub, J., Snary, D., Bodmer, W. F., & Mather, S. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181353498 · Cited by 11 · see citing works
The Development of Deep Brain Stimulation for Movement Disorders
Greek, R. (2012) · Journal of Clinical Research & Bioethics · doi:10.4172/2155-9627.1000137 · Cited by 10 · see citing works
Models for Evaluation of Targeted Therapies of Metastatic Disease
Eccles, S. A. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-100-8_17 · Cited by 10 · see citing works
Greek, R., & Hansen, L. A. (2016) · Biological Systems Open Access · doi:10.4172/2329-6577.1000109 · Cited by 9 · see citing works
Preclinical Screening for New Anticancer Agents
Burger, A. M., & Fiebig, H. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-734-5_2 · Cited by 9 · see citing works
Comparison of Dog and Pig Models for Testing Substernal Cardiac Compression Devices
Trumble, D. R., & Magovern, J. A. (2004) · ASAIO Journal · doi:10.1097/01.mat.0000123802.94214.75 · Cited by 8 · see citing works
The Ethical Implications for Humans in Light of the Poor Predictive Value of Animal Models
Greek, R. (2014) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2014.516129 · Cited by 8 · see citing works
Does Apoptosis Contribute to Tumor Cell Sensitivity to Anticancer Agents?
Brown, J. M., & Wouters, B. G. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-720-8_1 · Cited by 8 · see citing works
Cardillo, T. M., Mostafa, A. A., Rossi, D. L., Liu, D., Chang, C., Sharkey, R. M., & Goldenberg, D. M. (2017) · Cancer Research · doi:10.1158/1538-7445.am2017-3193 · Cited by 8 · see citing works
Sucharitha, A. (2023) · doi:10.23880/accp-16000102 · Cited by 7 · see citing works
Oliveira, R. C., Gomes, M. A., Abrantes, A. M., Tavares-da-Silva, E., Oliveira, M. C., Laranjo, M., Queiros, D., Casalta‐Lopes, J., Pires, A. S., Carvalho, L., et al. (2018) · Pathophysiology · doi:10.1016/j.pathophys.2018.02.002 · Cited by 7 · see citing works
Stone, H. B., Dewey, W. C., Wallace, S. S., & Coleman, C. N. (1998) · Radiation Research · doi:10.2307/3579849 · Cited by 7 · see citing works
Takimoto, C. H. M., & Wick, M. J. (2007) · Elsevier eBooks · doi:10.1016/b978-012369417-1/50069-9 · Cited by 6 · see citing works
Maurer-Gebhard, M., Schmidt, M., Azémar, M., Stöcklin, E., Wels, W. S., & Groner, B. (1999) · Hybridoma · doi:10.1089/hyb.1999.18.69 · Cited by 6 · see citing works
YAMADA, A., Kitano, S., & Matsusaki, M. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101097 · Cited by 5 · see citing works
How and Why to Apply the Latest Technology*
Czarnik, A. W., & Mei, H. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00048-1 · Cited by 5 · see citing works
Mouse models for generating P53 gene mutation spectra
Zielinski, B., Liu, Z., Hollstein, M. C., Hergenhahn, M., & Luo, J. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(02)00160-1 · Cited by 5 · see citing works
Evaluation the multi-organs toxicity of methamphetamine (METH) in rats
Ahmadi, I., & Foruozandeh, H. (2019) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2019.07.007 · Cited by 5 · see citing works
The development of molecularly targeted anticancer therapies: an Eli Lilly and Company perspective.
Wl, P., & Weitzman, A. (2005) · PubMed · Cited by 4 · see citing works
Liu, Y., Eu, K. W., Seow‐Choen, F., & Cheah, P. Y. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0441-7 · Cited by 4 · see citing works
Evaluation of Near Infrared Dyes as Markers of P-Glycoprotein Activity in Tumors
Semenenko, I., Portnoy, E., Aboukaoud, M., Guzy, S., Shmuel, M., Itzhak, G., & Eyal, S. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00426 · Cited by 4 · see citing works
Baird, R. D., & Workman, P. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-664-5_18 · Cited by 4 · see citing works
Persidis, A. (1998) · Nature Biotechnology · doi:10.1038/nbt0198-100 · Cited by 4 · see citing works
Use of new cancer drugs in India
Pal, S. K. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00579-4 · Cited by 4 · see citing works
Greek, R. (2014) · Biological Systems Open Access · doi:10.4172/2329-6577.1000124 · Cited by 3 · see citing works
The Use of Pediatric Patient-Derived Xenografts for Identifying Novel Agents and Combinations
Kurmasheva, R. T., & Houghton, P. J. (2017) · Molecular and translational medicine · doi:10.1007/978-3-319-57424-0_11 · Cited by 3 · see citing works
Takimoto, C. H. M., & Wick, M. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385471-1.00031-3 · Cited by 3 · see citing works
Chae, Y. J., Kim, J.-I., Heo, H., Woo, C., Kim, S., Kim, M. J., Choi, J. R., Kim, D. H., Woo, D., Kim, K. W., et al. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.06.006 · Cited by 3 · see citing works
Models for Evaluation of Targeted Therapies of Invasive and Metastatic Disease
Eccles, S. A. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-968-0_19 · Cited by 2 · see citing works
3D‐Biodruck von Gewebe‐ und Organmodellen
Pati, F., Gantelius, J., & Svahn, H. A. (2016) · Angewandte Chemie · doi:10.1002/ange.201505062 · Cited by 2 · see citing works
Biology meets drug development : the biography of a 'miracle' drug, the interferons
Pieters, T. (1999) · doi:10.26481/dis.19991105tp · Cited by 2 · see citing works
Taylor, D. E., & Fisher, R. J. (2003) · IEEE Annual Northeast Bioengineering Conference (NEBEC) · doi:10.1109/nebc.1999.755756 · Cited by 2 · see citing works
Multidrug resistance in solid tumours
Nicolantonio, F. D. (2004) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 2 · see citing works
Harris, S. (2016) · CRC Press eBooks · doi:10.1201/9781420003871-12 · Cited by 2 · see citing works
Monotherapy cancer drug-blind response prediction is limited to intraclass generalization
Herbert, W. G., Chia, N., Jensen, P. A., & Walther-Antonio, M. R. S. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013232 · Cited by 1 · see citing works
Shuler, M. L. (1999) · The electrical engineering handbook/Electrical engineering handbook series/Electrical engineering handbook · doi:10.1201/9781420049510.ch97 · Cited by 1 · see citing works
Fisher, R. J. (2012) · CRC Press eBooks · doi:10.1201/b12937-2 · Cited by 1 · see citing works
Takimoto, C. H. M., Wick, M. J., Agoram, B. M., & Jin, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819869-8.00031-8 · Cited by 1 · see citing works
Potential Advantages of Using Biomimetic Alternatives
Davies, J. A. (2012) · doi:10.1002/9781119940685.ch1 · Cited by 1 · see citing works
Patients Are Not Rodents Writ Large
Greek, R. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182323f78 · Cited by 1 · see citing works
Workman, P. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-222-7_17 · Cited by 1 · see citing works
Effects of a novel anticancer agent on ras- and src- transformed 10T 1/2 Cells
Giltnane, J. M. (1999)
Animals and Medicine Do Animal Experiments Predict Human Responses
Shank, N., Greek, R. Y., & Greek, J. (2007)
Byrne, P. (2006)
A Transgenic Zebrafish Model of Signaling Through Toll-Like Receptors
Elsberry, D. (2014) · J. Willard Marriott Library · doi:10.26053/0h-ekqw-xxg0
Ethics and Evidence Regarding Animal Subjects Research: Splitting Hares–or Swallowing Camels?
Norman, G. A. V. (2015) · Springer eBooks · doi:10.1007/978-3-319-15949-2_17
Folkvord, S. (2009) · NORA - Norwegian Open Research Archives
Fisher, R. J. (1999) · The electrical engineering handbook/Electrical engineering handbook series/Electrical engineering handbook · doi:10.1201/9781420049510.ch95
(2000) · Nature Biotechnology · doi:10.1038/80088
Shuler, M. L., Harris, S., Li, X., & Esch, M. B. (2012) · CRC Press eBooks · doi:10.1201/b12937-6
Guidance for Adolescents in Kota Atas Sabang Neighborhood Regarding the Dangers of Drug Abuse
Khalis, M. (2023) · International Journal Education and Computer Studies (IJECS) · doi:10.35870/ijecs.v3i1.1801
Translating Preclinical Studies into the Clinic: Assays and Endpoints Selected to Determine Efficacy
Horsman, M. R., & Siemann, D. W. (2025) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-25-0739
- Authors
- Gura, T.
- Affiliations
- Trisha Gura is a writer in Cleveland, Ohio.
- Corresponding author
- Gura, Trisha
- Venue
- Science
- Published
- 1997-11-07
- Volume
- 278
- Issue
- 5340
- Pages
- 1041-1042
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1936609228
- Cited by
- 92
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 2 · 2021: 2 · 2019: 3 · 2018: 4 · 2017: 2 · 2016: 6 · 2015: 1 · 2014: 3 · 2013: 6 · 2012: 9
- Type
- other
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Reproductive Medicine › Science, Research, and Medicine
- Keywords
- anticancer drug discovery, drug screening, xenografts, animal-to-human translation, genetically engineered mouse models, translational oncology
- MeSH terms
- Animals, Antineoplastic Agents, Disease Models, Animal, Drug Screening Assays, Antitumor, Humans, Mice, Mutant Strains, Mutation, Neoplasm Transplantation, Neoplasms, Oncogenes, Transplantation, Heterologous, Tumor Cells, Cultured, Tumor Stem Cell Assay, Genes, Tumor Suppressor, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review